Clinical Trials Sponsored by SciCORE Basel

Total 1471 results

University Hospital, Basel, Switzerland
sciCORE University of Basel; Leonhard Med IT ETH Zurich; Swiss Institute of Bioinformatics

Recruiting

A Systems Approach to Predict the Outcome of SARS-CoV-2 in the Population of a City; COVID-19

SARS Coronavirus (SARS-CoV-2) Infection

Switzerland
SciClone Pharmaceuticals

Not yet recruiting

Naxitamab and Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) Combined With Isotretinoin for Maintenance Treatment of Patients With High-Risk Neuroblastoma in First Complete Response.

Neuroblastoma
Tricore, Inc

Not yet recruiting

Evaluation of a Screen and Treat Protocol for Influenza

Influenza
SciClone Pharmaceuticals

Completed

Extension Study SCI-SCV-HCV-P2-001: Long-Term FU in Subj Who Opt for Retreatment With Peg-INF and RBV After Completing Treatment in HCV

Chronic Hepatitis C

United States
SciClone Pharmaceuticals

Completed

Thymosin Plus PEG-Interferon in Non-Cirrhotic Hepatitis C Patients Who Did Not Respond to Interferon or Interferon Plus Ribavirin

Hepatitis C | Hepatitis C, Chronic

United States, Puerto Rico
University Hospital, Basel, Switzerland
Botnar Research Centre for Child Health (BRCCH); sciCORE Basel; Department of...

Recruiting

Neural Network to Calculate Morphology of the Cleft Palate to Reduce Cleft Lip and Palate Treatment Burden.

Cleft Palate | Orofacial Cleft

Switzerland
SciClone Pharmaceuticals

Recruiting

PT-112 (Phosplatin's Platinum) Combine With Gemcitabine Injection for Advanced Solid Tumors

Biliary Tract Cancer

China
SciClone Pharmaceuticals

Unknown

An Open-label Phase I/II Clinical Trial of PT-112 Injection for Advanced Solid Tumors and Advanced Hepatocellular Carcinoma

Advanced Solid Tumors

China
SciClone Pharmaceuticals

Unknown

First Line Bio-immunotherapy With Thymosin Alpha 1 in Patients With Sensitizing EGFR Mutation Positive Non Small Cell Lung Cancer Who Are Taking Standard of Care Therapy

EGFR Mutation Positive Non Small Cell Lung Cancer

Italy
SciClone Pharmaceuticals

Unknown

Thymosin Alpha 1 Plus Maintenance Therapy With the Standard of Care (SoC) in Patients With Metastatic Non-Small Cell Lung Cancer (NSCLC), EGFR Wild Type

Non-Small Cell Lung Cancer

Italy
SciClone Pharmaceuticals

Unknown

Study to Evaluate the Efficacy and Safety of Three Different Doses of SCV 07 in Attenuating Oral Mucositis in Subjects With Head and Neck Cancer

Oral Mucositis

United States
SciClone Pharmaceuticals

Completed

Proof-of-concept Study to Evaluate the Safety and Immunomodulatory Effects of SCV 07 as Monotherapy or in Combination With Ribavirin in Noncirrhotic Subjects With Chronic Hepatitis C Who Have Relapsed

Chronic Hepatitis C

United States
SciClone Pharmaceuticals

Terminated

Phase II Study to Evaluate Efficacy and Safety of RP101 in Combination With Gemcitabine (RP101)

Pancreatic Cancer

United States, Chile, Spain, Brazil, Argentina, France, Germany, Hungary, Netherlands, Peru, Poland, Romania, United Kingdom
SciClone Pharmaceuticals

Completed

Dose Ranging Study to Assess the Safety and Efficacy of SCV-07 for the Delay to Onset of Severe Oral Mucositis in Patients Receiving Chemoradiation Therapy for Head and Neck Cancer (SCV-07 OM)

Head and Neck Cancer | Oral Mucositis

United States
SciClone Pharmaceuticals

Completed

A Trial of Thymalfasin in Adult Patients With Hepatocellular Carcinoma

Carcinoma, Hepatocellular

United States
SciClone Pharmaceuticals

Completed

Thymosin Plus PEG-Interferon in Hepatitis C Patients With Cirrhosis Who Did Not Respond to Interferon or Interferon Plus Ribavirin

Hepatitis C | Hepatitis C, Chronic

United States, Puerto Rico
Vicore Pharma AB

Completed

A Trial to Investigate Recovery From COVID-19 With C21 in Adult Subjects (ATTRACT-3)

COVID-19

Philippines, United States, Brazil, India, Russian Federation, Colombia, Argentina, Czechia, South Africa, Ukraine
Vicore Pharma AB

Completed

A Trial to Evaluate the Impact of C21 on the Exposure of 4 Substrates in Healthy Volunteers

Drug Interaction

Sweden
SynCore Biotechnology Co., Ltd.

Terminated

Study of SCB01A in Patient With Head and Neck Cancer

Head and Neck Squamous Cell Carcinoma

Taiwan
SynCore Biotechnology Co., Ltd.

Terminated

To Evaluate the Efficacy and Safety of SCB01A in Subjects With r/m Squamous Cell Head and Neck Cancer

Head and Neck Neoplasms

Taiwan
SynCore Biotechnology Co., Ltd.

Suspended

A Trial Evaluating the Efficacy and Safety of EndoTAG®-1 in Combination With Paclitaxel and Gemcitabine Compared With Paclitaxel and Gemcitabine as First-line Therapy in Patients With Visceral Metastatic Triple-negative Breast Cancer

Triple-Negative Breast Cancer

Taiwan
University Hospital, Basel, Switzerland
Schulzahnklinik Basel; Volkszahnklinik Basel

Completed

Salivary Cytokines as Biomarker for Oral Health (Cytosal)

Neoplasms

Switzerland
University Hospital, Basel, Switzerland
propatient Basel

Completed

Tele-Stroke: Prehospital Identification of Patients With Suspected Stroke Using Onsite Mobile Telemedicine - Feasibility (Tele-Stroke)

Stroke, Acute

Switzerland
University Hospital, Basel, Switzerland
University of Basel; University Psychiatric Clinics Basel

Recruiting

LSD-Perceptual-Choice-Study (LUCY)

LSD Reaction

Switzerland
Rehab Basel

Unknown

Locomotor Training in Individuals With Incomplete Spinal Cord Injury. A Pilot Study

Incomplete Spinal Cord Injury

Switzerland
University of Basel
University Hospital, Basel, Switzerland

Completed

Comparison of PET/CT and Ultrasound in Staging of Malignant Melanoma

Malignant Melanoma
University Hospital, Basel, Switzerland
Diabetes Association Basel

Completed

Diabetes-Related Discrimination at Workplace and by Insurances

Insulin-Treated Diabetes Mellitus
University Hospital, Basel, Switzerland
University of Basel

Completed

iECG: Recording Chest Leads Using a Smartwatch With a Digital Image Processing Algorithm (iECG)

Electrocardiogram

Switzerland
University Hospital, Basel, Switzerland
propatient foundation Basel

Completed

Probability of Target Attainment With Standard Intermittent Bolus Administration of Cefazolin in Patients With Complicated Infections Caused by Staphylococcus Aureus (TARGET II)

Staphylococcus Aureus Infection

Switzerland
University Hospital, Basel, Switzerland
University of Basel

Completed

Bioavailability Mechanistic Study of Hot-Melt Extruded Amorphous Solid Dispersions (BEAD)

Biological Availability | Amorphous Solid Dispersions

Switzerland
University Hospital, Basel, Switzerland
University of Basel

Completed

Smartphone Application, Mood and Stress

Stress | Mood | Placebo Effect | Smartphone Application

Switzerland
Vicore Pharma AB

Completed

First-in-human Trial to Evaluate the Safety, Tolerability and Pharmacokinetics of C106 in Healthy Subjects

Idiopathic Pulmonary Fibrosis | Pulmonary Hypertension | Tolerance | Safety Issues

Sweden
Vicore Pharma AB

Completed

A Trial to Evaluate the Effect of C21 on Endothelial Dysfunction in Subjects With Type 2 Diabetes

Endothelial Dysfunction | Type2diabetes

Sweden
Vicore Pharma AB

Completed

Retrospective Evaluation of Lung Pathology in Subjects With COVID-19 (ATTRACT-2)

Covid19

India
sigma-tau i.f.r. S.p.A.
SciClone Pharmaceuticals

Completed

Thymosin Alpha-1 in Combination With Peg-Interferon Alfa- 2a and Ribavirin for the Therapy of Chronic Hepatitis C Nonresponsive to the Combination of IFN and Ribavirin.

Chronic Hepatitis C

Spain, Italy, France, Germany, Greece
University Hospital, Basel, Switzerland
University of Basel

Recruiting

REtinal Markers In Neuroinflammatory Diseases ("REMIND")

Multiple Sclerosis | Neuroinflammatory Diseases

Switzerland
University Hospital, Basel, Switzerland
University of Basel

Recruiting

Virtual Reality Training for Laparoscopic Cholecystectomy

Medical Education | Virtual Reality | Laparoscopy | Bile Duct Injury | Gallbladder

Switzerland
Clarunis - Universitäres Bauchzentrum Basel
University of Basel

Completed

Home- vs. Hospital-based Surgical Training

Surgical Training

Switzerland
University Hospital, Basel, Switzerland
University of Basel

Completed

Polymedication-Check With Insight in Patients' Medication Organisation and Comprehension of Generics

Medication Adherence | Medication Therapy Management

Switzerland
University Hospital, Basel, Switzerland
University of Basel

Completed

Development of a Questionnaire to Assess Patient Knowledge About Non-vitamin K Anticoagulants (NOAC)

Atrial Fibrillation | Deep Vein Thrombosis | Pulmonary Embolism

Switzerland
University Hospital, Basel, Switzerland
University of Basel

Completed

Medication Review Focusing on Anticoagulation Therapy in Swiss Community Pharmacies

Drug Therapy Management

Switzerland
Vicore Pharma AB
Orphan Reach

Completed

Safety and Efficacy of C21 in Subjects With COVID-19

COVID-19

India, United Kingdom
SynCore Biotechnology Co., Ltd.

Completed

EndoTAG-1+GEM vs GEM in Patients With Locally Advanced/Metastatic Pancreatic Adenocarcinoma Failed on FOLFIRINOX

Pancreatic Adenocarcinoma | Metastatic Pancreas Cancer | Locally Advanced Pancreatic Cancer

United States, Korea, Republic of, Taiwan, France, Hungary, Israel, Russian Federation
SynCore Biotechnology Co., Ltd.

No longer available

Long-Term Compassionate Use Study for Continued Administration of SCB01A-01

Malignant Solid Tumour
SynCore Biotechnology Co., Ltd.

Completed

A Dose Escalation Study of SCB01A in Subjects With Advanced Solid Tumors Who Have Failed Standard Therapy

Solid Tumors

Taiwan
SciClone Pharmaceuticals International (Cayman)...
Parexel; National Cheng-Kung University Hospital

Unknown

An Open-Label Phase I/II Clinical Study of PT-112 in Combination With Docetaxel in Subjects With Advanced Solid Tumor in a Phase I Dose Escalation Study and in Subjects With Non-Small Cell Lung Cancer (NSCLC) in a Phase II Dose Confirmation Study

Non-Small Cell Lung Cancer | Advanced Solid Tumor

Taiwan
University Hospital, Basel, Switzerland
University Psychiatric Clinics Basel

Recruiting

Virtual Reality Aggression Prevention Training (VRAPT) for Forensic Psychiatric Patients

Forensic Psychiatry

Switzerland
University Hospital, Basel, Switzerland
Freie Akademische Gesellschaft Basel

Recruiting

Spinal Cord Lesion Detection in Multiple Sclerosis Using Novel MRI Sequences

Multiple Sclerosis (MS)

Switzerland
University Hospital, Basel, Switzerland
GMP network of Basel

Completed

Adoptive Tumor-infiltrating Lymphocyte Transfer With Nivolumab for Melanoma (BaseTIL)

Advanced Melanoma

Switzerland
University Hospital, Basel, Switzerland
University Children's Hospital Basel

Completed

Copeptin for Prediction of Treatment Response in Children With Monosymptomatic Nocturnal Enuresis (MEN). (COMEN)

Nocturnal Enuresis

Switzerland

Clinical Trials Sponsored by SciCORE Basel

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Australia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations